Abstract
Introduction. Studies have shown variation of the clinical presentation of the hydatidiform mole (HM) and of the risk of developing gestational trophoblastic neoplasia (GTN) in women e 40 years. The incidence of complete hydatidiform mole (CHM), as well as the need of chemotherapy after CHM, are dramatically affected by the increasing of age. However, there is a general trend towards dela…